INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment Doxycycline is indicated for the treatment of the following infections: â€¢ Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae. â€¢ Respiratory tract infections caused by Mycoplasma pneumoniae. â€¢ Lymphogranuloma venereum caused by Chlamydia trachomatis . â€¢ Psittacosis (ornithosis) caused by Chlamydophila psittaci . â€¢ Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. â€¢ Inclusion conjunctivitis caused by Chlamydia trachomatis . â€¢ Uncomplicated urethral, endocervical, or rectal infections in adults caused by Chlamydia trachomatis . â€¢ Nongonococcal urethritis caused by Ureaplasma urealyticum . â€¢ Relapsing fever due to Borrelia recurrentis . Doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: â€¢ Chancroid caused by Haemophilus ducreyi . â€¢ Plague due to Yersinia pestis . â€¢ Tularemia due to Francisella tularensis . â€¢ Cholera caused by Vibrio cholerae . â€¢ Campylobacter fetus infections caused by Campylobacter fetus. â€¢ Brucellosis due to Brucella species (in conjunction with streptomycin). â€¢ Bartonellosis due to Bartonella bacilliformis . â€¢ Granuloma inguinale caused by Klebsiella granulomatis . Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. Doxycycline is indicated for treatment of infections caused by the following gram-negative bacteria, when bacteriologic testing indicates appropriate susceptibility to the drug: â€¢ Escherichia coli . â€¢ Enterobacter aerogenes . â€¢ Shigella species. â€¢ Acinetobacter species. â€¢ Respiratory tract infections caused by Haemophilus influenzae . â€¢ Respiratory tract and urinary tract infections caused by Klebsiella species. Doxycycline is indicated for treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: â€¢ Upper respiratory infections caused by Streptococcus pneumoniae. â€¢ Anthrax due to Bacillus anthracis , including inhalational anthrax (post-exposure): to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis . When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections: â€¢ Uncomplicated gonorrhea caused by Neisseria gonorrhoeae . â€¢ Syphilis caused by Treponema pallidum . â€¢ Yaws caused by Treponema pallidum subspecies pertenue . â€¢ Listeriosis due to Listeria monocytogenes . â€¢ Vincentâ€™s infection caused by Fusobacterium fusiforme . â€¢ Actinomycosis caused by Actinomyces israelii . â€¢ Infections caused by Clostridium species. In acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides. In severe acne, doxycycline may be useful adjunctive therapy. Prophylaxis Doxycycline is indicated for the prophylaxis of malaria due to Plasmodium falciparum in short-term travelers (< 4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains. (See DOSAGE AND ADMINISTRATION section and Information for Patients subsection of the PRECAUTIONS section.)
Mylan Pharmaceuticals Inc.
HOW SUPPLIED Doxycycline Hyclate Tablets, USP are available containing doxycycline hyclate, USP equivalent to 100 mg of doxycycline. The 100 mg tablets are beige, film-coated, round, unscored tablets debossed with MYLAN over 167 on one side of the tablet and 100 on the other side. They are available as follows: NDC 0378-0167-89 bottles of 50 tablets NDC 0378-0167-05 bottles of 500 tablets Store at 20Â° to 25Â°C (68Â° to 77Â°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site